- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | HeartBeam CEO joins board to support commercialization efforts | ||
| Mo | Integra LifeSciences posts mixed Q1, cuts EPS guidance for tariff impact | ||
| Mo | Zimmer Biomet seeks to be 'boldest medtech company on Earth' | ||
| Mo | Smith+Nephew to take Cori surgical robot on European roadshow | ||
| Mo | Endogenex says ReCET system study shows promise for type 2 diabetes patients | ||
| 02.05. | Inquis Medical study backs Aventus thrombectomy system | ||
| 02.05. | Nuro hits communication milestone with non-surgical neurotech | ||
| 02.05. | ElectroCore completes acquisition of NeuroMetrix | ||
| 02.05. | iRhythm stock gets a boost on Q1 results, continued momentum with Zio launch in Japan | ||
| 02.05. | Aktiia raises $42M for blood pressure monitoring tech, rebrands to Hilo | ||
| 02.05. | HistoSonics reportedly eyes sale at $2.5B valuation with Medtronic, GE HealthCare, J&J interest | ||
| 02.05. | Neuralink wins FDA breakthrough nod for treating speech impairment | ||
| 01.05. | Stryker posts strong Q1 results, expects $200M tariff costs | ||
| 01.05. | Baxter beats the Street in Q1, increases full-year guidance | ||
| 01.05. | Facing up to $300M in tariff costs, Cardinal Health lays off employees | ||
| 01.05. | Facing up to $300M in tariff costs, Cardinal Heath lays off employees | ||
| 01.05. | Element Sciences earns FDA premarket approval for wearable defibrillator patch | ||
| 01.05. | Intuitive earns expanded FDA nod for da Vinci single port system | ||
| 01.05. | Resmed acquires virtual diagnostics company VirtuOx | ||
| 01.05. | Edwards wins FDA nod for TAVR in aortic stenosis without symptoms | ||
| 01.05. | Precision Neuroscience strengthens leadership following FDA clearance for BCI tech | ||
| 01.05. | BD posts mixed Q2, adjusts guidance for tariff impact | ||
| 30.04. | Spark Biomedical closes $15M Series A for wearable neurostim | ||
| 30.04. | How Zimmer Biomet CEO Ivan Tornos recruited Arnold Schwarzenegger - a mostly true story from DeviceTalks Boston | ||
| 30.04. | Surmodics stock takes another hit on Q2 miss and 2025 guidance |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .